{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T10:28:20Z","timestamp":1783506500043,"version":"3.55.0"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81770297"],"award-info":[{"award-number":["81770297"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.ejphar.2026.178538","type":"journal-article","created":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T16:12:46Z","timestamp":1768061566000},"page":"178538","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["SIRT1-mediated YAP deacetylation suppresses myocardial hypertrophy in diabetic cardiomyopathy"],"prefix":"10.1016","volume":"1014","author":[{"given":"Hongwei","family":"Ye","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linlin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anbo","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengjie","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shicheng","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiahui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7599-4295","authenticated-orcid":false,"given":"Qin","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2026.178538_bib1","article-title":"Cardiac hypertrophy and fibrosis were attenuated by olive leaf extract treatment in a rat model of diabetes","volume":"46","author":"Aa","year":"2022","journal-title":"J. Food Biochem."},{"key":"10.1016\/j.ejphar.2026.178538_bib2","doi-asserted-by":"crossref","first-page":"3213","DOI":"10.1161\/CIRCULATIONAHA.106.679597","article-title":"Diabetic cardiomyopathy revisited","volume":"115","author":"Boudina","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2026.178538_bib3","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.freeradbiomed.2021.03.046","article-title":"Therapeutic potential of targeting oxidative stress in diabetic cardiomyopathy","volume":"169","author":"Byrne","year":"2021","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.ejphar.2026.178538_bib4","doi-asserted-by":"crossref","DOI":"10.1074\/jbc.RA118.006123","article-title":"Yes-Associated Protein (YAP) mediates adaptive cardiac hypertrophy in response to pressure overload","author":"Byun","year":"2019","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2026.178538_bib5","doi-asserted-by":"crossref","DOI":"10.1007\/s12265-024-10488-9","article-title":"Lipoamide attenuates hypertensive myocardial hypertrophy through PI3K\/Akt-Mediated Nrf2 signaling pathway","author":"Cao","year":"2024","journal-title":"J. Cardiovasc. Transl. Res."},{"key":"10.1016\/j.ejphar.2026.178538_bib6","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1002\/dmrr.689","article-title":"Role of endothelin-1, sodium hydrogen exchanger-1 and mitogen activated protein kinase (MAPK) activation in glucose-induced cardiomyocyte hypertrophy","volume":"23","author":"Chen","year":"2007","journal-title":"Diabetes Metab. Res. Rev."},{"key":"10.1016\/j.ejphar.2026.178538_bib7","doi-asserted-by":"crossref","first-page":"3977","DOI":"10.1074\/jbc.M112.436311","article-title":"Yes-associated protein isoform 1 (Yap1) promotes cardiomyocyte survival and growth to protect against myocardial ischemic injury","volume":"288","author":"Del Re","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2026.178538_bib8","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1177\/1535370219840981","article-title":"Effect of Irbesartan on AGEs-RAGE and MMPs systems in rat type 2 diabetes myocardial-fibrosis model","volume":"244","author":"Hongwei","year":"2019","journal-title":"Exp. Biol. Med."},{"key":"10.1016\/j.ejphar.2026.178538_bib9","doi-asserted-by":"crossref","first-page":"662","DOI":"10.3390\/biomedicines11030662","article-title":"Emerging therapy for diabetic cardiomyopathy: from molecular mechanism to clinical practice","volume":"11","author":"Hsuan","year":"2023","journal-title":"Biomedicines"},{"key":"10.1016\/j.ejphar.2026.178538_bib10","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.freeradbiomed.2019.10.416","article-title":"Activation of ALDH2 attenuates high glucose induced rat cardiomyocyte fibrosis and necroptosis","volume":"146","author":"Kang","year":"2020","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.ejphar.2026.178538_bib11","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/6190504","article-title":"Activation of ALDH2 with low concentration of ethanol attenuates myocardial Ischemia\/Reperfusion Injury in Diabetes rat model","volume":"2016","author":"Kang","year":"2016","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.ejphar.2026.178538_bib12","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.biopha.2017.03.056","article-title":"The role of SIRT1 in diabetic cardiomyopathy","volume":"90","author":"Karbasforooshan","year":"2017","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ejphar.2026.178538_bib13","doi-asserted-by":"crossref","DOI":"10.1172\/JCI150595","article-title":"YAP mediates compensatory cardiac hypertrophy through aerobic glycolysis in response to pressure overload","volume":"132","author":"Kashihara","year":"2022","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.ejphar.2026.178538_bib14","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1038\/s41401-021-00820-3","article-title":"Lupeol protects against cardiac hypertrophy via TLR4-PI3K-Akt-NF-\u03baB pathways","volume":"43","author":"Li","year":"2022","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.ejphar.2026.178538_bib15","doi-asserted-by":"crossref","first-page":"4989","DOI":"10.7150\/thno.107367","article-title":"Inhibition of CAV1 attenuates diabetic cardiomyopathy through reducing ferroptosis via activating NRF2\/GCLC signaling pathway","volume":"15","author":"Li","year":"2025","journal-title":"Theranostics"},{"key":"10.1016\/j.ejphar.2026.178538_bib16","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1111\/jcmm.14870","article-title":"Allopurinol reduces oxidative stress and activates Nrf2\/p62 to attenuate diabetic cardiomyopathy in rats","volume":"24","author":"Luo","year":"2020","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.ejphar.2026.178538_bib17","doi-asserted-by":"crossref","first-page":"3320","DOI":"10.1093\/cvr\/cvac014","article-title":"The role of the Hippo pathway in autophagy in the heart","volume":"118","author":"Maejima","year":"2023","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.ejphar.2026.178538_bib18","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1002\/jcb.30197","article-title":"Protein acetylation effects on enzyme activity and metabolic pathway fluxes","volume":"123","author":"Mar\u00edn-Hern\u00e1ndez","year":"2022","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.ejphar.2026.178538_bib19","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1161\/CIRCRESAHA.108.180042","article-title":"Lats2 is a negative regulator of myocyte size in the heart","volume":"103","author":"Matsui","year":"2008","journal-title":"Circ. Res."},{"key":"10.1016\/j.ejphar.2026.178538_bib20","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2021.746382","article-title":"Left ventricular hypertrophy in diabetic cardiomyopathy: a target for intervention","volume":"8","author":"Mohan","year":"2021","journal-title":"Front. Cardiovasc. Med."},{"key":"10.1016\/j.ejphar.2026.178538_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.abb.2022.109198","article-title":"YAP1 induces hyperglycemic stress-mediated cardiac hypertrophy and fibrosis in an AKT-FOXM1 dependent signaling pathway","volume":"722","author":"Mondal","year":"2022","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.ejphar.2026.178538_bib22","article-title":"The alteration of Hippo\/YAP signaling in the development of hypertrophic cardiomyopathy","volume":"109","author":"P","year":"2014","journal-title":"Basic Res. Cardiol."},{"key":"10.1016\/j.ejphar.2026.178538_bib23","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.907757","article-title":"Signaling pathways related to oxidative stress in diabetic cardiomyopathy","volume":"13","author":"Peng","year":"2022","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.ejphar.2026.178538_bib24","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.jdiacomp.2015.04.012","article-title":"PPAR\u03b3-PI3K\/AKT-NO signal pathway is involved in cardiomyocyte hypertrophy induced by high glucose and insulin","volume":"29","author":"Peng","year":"2015","journal-title":"J. Diabet. Complicat."},{"key":"10.1016\/j.ejphar.2026.178538_bib25","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s00592-020-01582-w","article-title":"YAP mediates the interaction between the Hippo and PI3K\/Akt pathways in mesangial cell proliferation in diabetic nephropathy","volume":"58","author":"Qian","year":"2021","journal-title":"Acta Diabetol."},{"key":"10.1016\/j.ejphar.2026.178538_bib26","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/0002-9149(72)90595-4","article-title":"New type of cardiomyopathy associated with diabetic glomerulosclerosis","volume":"30","author":"Rubler","year":"1972","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.ejphar.2026.178538_bib27","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2023.1264382","article-title":"Epigenome-wide DNA methylation profiling in comparison between pathological and physiological hypertrophy of human cardiomyocytes","volume":"14","author":"Shi","year":"2023","journal-title":"Front. Genet."},{"key":"10.1016\/j.ejphar.2026.178538_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2022.102334","article-title":"Inhibition of nuclear deacetylase Sirtuin-1 induces mitochondrial acetylation and calcium overload leading to cell death","volume":"53","author":"Sun","year":"2022","journal-title":"Redox Biol."},{"key":"10.1016\/j.ejphar.2026.178538_bib29","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/5913374","article-title":"Oxidative stress signaling mediated pathogenesis of diabetic Cardiomyopathy","author":"Tang","year":"2022","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.ejphar.2026.178538_bib30","doi-asserted-by":"crossref","first-page":"6048","DOI":"10.1038\/ncomms7048","article-title":"The Hippo pathway effector YAP is a critical regulator of skeletal muscle fibre size","volume":"6","author":"Watt","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejphar.2026.178538_bib31","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/s41420-023-01319-y","article-title":"Verteporfin reverses progestin resistance through YAP\/TAZ-PI3K-Akt pathway in endometrial carcinoma","volume":"9","author":"Wei","year":"2023","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.ejphar.2026.178538_bib32","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/s41419-020-2343-1","article-title":"Laminar flow inhibits the Hippo\/YAP pathway via autophagy and SIRT1-mediated deacetylation against atherosclerosis","volume":"11","author":"Yuan","year":"2020","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ejphar.2026.178538_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2023.106666","article-title":"PXR triggers YAP-TEAD binding and Sirt2-driven YAP deacetylation and polyubiquitination to promote liver enlargement and regeneration in mice","volume":"188","author":"Zhang","year":"2023","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.ejphar.2026.178538_bib34","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s11658-025-00760-4","article-title":"Posttranslational modifications of YAP\/TAZ: molecular mechanisms and therapeutic opportunities","volume":"30","author":"Zhang","year":"2025","journal-title":"Cell. Mol. Biol. Lett."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299926000208?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299926000208?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T20:59:54Z","timestamp":1769115594000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299926000208"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":34,"alternative-id":["S0014299926000208"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2026.178538","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"SIRT1-mediated YAP deacetylation suppresses myocardial hypertrophy in diabetic cardiomyopathy","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2026.178538","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"178538"}}